CD30-positivity, typically measured by immunohistochemistry in tissue specimens, is defined as expression levels of ≥ 75% for ALCL; however, specific cut-offs for other tumor types are not universally defined, due to variability in expression levels [1]. Here, TNFRSF8 is linked to anaplastic large cell lymphoma.